Microbiology News and Research

RSS

New discovery explains how a common gene variant may increase cancer risks

Roughly 15 percent of the population carries a gene variant that may increase the risk of developing cancer. The cause of this increased risk has been unknown until now. But now a research team at Stockholm University in Sweden can explain why.

21 Mar 2006

Novel vaccine approach to listeria - potential protection against other intracellular bacterial pathogens

When bacterial pathogens attack the surface of a cell, vaccine-induced antibodies can mount a formidable defense and fend off the bad bugs.

21 Mar 2006

Movement routes key to predicting spread of infectious diseases

Knowledge of 'movement routes' is the key to predicting the pattern of spread of infectious diseases of humans, and similar data could be crucial to understand animal disease risks, says team from the University of Edinburgh.

20 Mar 2006

Study to Rituximab's potential to preserve insulin production in newly diagnosed type 1 diabetics

A drug used to treat lymphoma, rheumatoid arthritis and other immune disorders may enable newly-diagnosed type 1 diabetics to save some of their pancreas function and thereby reduce their susceptibility to long-term complications.

20 Mar 2006

New tools in the fight against pneumococci

New tools in the fight against pneumococci - the bugs targeted by vaccines recently announced by the Department of Health - are described by a team led by scientists from the Wellcome Trust Sanger Institute.

13 Mar 2006

Scientists create a mosquito resistant to Type 2 dengue fever virus

Researchers have successfully created a genetically engineered mosquito that shows a high level of resistance against the most prevalent type of dengue fever virus, providing a powerful weapon against a disease that infects 50 million people each year.

9 Mar 2006

Dramatic increase in antibiotic-resistant staph infections

Staph infections resistant to antibiotics, previously only associated with hospitalization or prior contact with the healthcare system, are now widespread in the community and coming home.

9 Mar 2006

Details of protein-cleaving complex key to microbe's survival may improve drug design

With the hope of designing more effective treatments for tuberculosis (TB), scientists from the U.S. Department of Energy's Brookhaven National Laboratory and collaborating institutions have published the first detailed reports on the biochemistry and structure of a protein-cleaving complex that is essential to the TB bacterium's survival.

9 Mar 2006

Researchers gain key insights into how different types of infection-fighting T-cells survive

T-cells, or lymphocytes, are the body's natural defense mechanism against infection, directly attacking foreign bodies such as bacteria and viruses.

7 Mar 2006

Genome signature tagging used to quickly identify and distinguish between pathogens and harmless microbes

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have developed a new, high-throughput technique for identifying the many species of microorganisms living in an unknown "microbial community."

6 Mar 2006

Scientists show how MRSA sidesteps hospital protection measures

The MRSA 'superbug' evades many of the measures introduced to combat its spread by infecting a common single-celled organism found almost everywhere in hospital wards, according to new research published in the journal Environmental Microbiology.

1 Mar 2006

Is persistent bacterial infection good for your health?

Bacteria are bad. Mothers and doctors, not to mention the cleaning product industry, repeatedly warn of their dangers. But a Stanford University School of Medicine microbiologist is raising the intriguing idea that persistent bacterial and viral infections have benefits.

27 Feb 2006

Cervical cancer vaccines in development

Two preventative vaccines, Gardasil (Merck) and Cervarix (GlaxoSmithKline) that work against the Human Papilloma virus (HPV) - a sexually transmitted infection and the primary cause of cervical cancer - are gaining favorable attention.

27 Feb 2006

Why people of African descent are more vulnerable to tuberculosis infection

A team of scientists has identified a cellular mechanism that may help explain the puzzle of why people of African descent are more susceptible to tuberculosis infection and why, once infected, they develop more severe states of the disease than whites.

27 Feb 2006

Atherosclerosis MAY be a result of bacteria from gum infection entering the bloodstream

New research is reinforcing the longstanding belief that a connection exists between periodontal disease, or severe gum inflammation, and cardiovascular disease.

23 Feb 2006

New oral vaccine against Pseudomonas aeruginosa

A new oral vaccine against Pseudomonas aeruginosa, a bacterium commonly known for afflicting patients with lung dysfunction, has shown to protect healthy human volunteers from infection say researchers from England and Australia.

23 Feb 2006

Ebola DNA vaccine shows promise

Vical Incorporated has announced that an Ebola vaccine candidate administered using Vical's proprietary DNA delivery technology was safe and well tolerated, and produced both antibody and T-cell Ebola-specific responses in all healthy volunteers who received the full 3 doses of vaccine.

21 Feb 2006

Gene mutation discovered that causes a rare form of Charcot-Marie-Tooth disease

A multi-national research team that includes a Saint Louis University neurologist has discovered a gene mutation that causes a rare form of Charcot-Marie-Tooth disease, an inherited progressive nerve disorder. The findings are published in an advance online issue of Nature Genetics

13 Feb 2006

New technology could replace time-intensive urine specimens

For the millions of people who suffer from urinary tract infections each year and the doctors who treat them, a promising new biosensor technology has been developed that may replace antiquated testing methods and save precious health care dollars.

12 Feb 2006

Faster screening test for methicillin-resistant Staphylococcus aureus

A new screening technique for methicillin-resistant Staphylococcus aureus (MRSA) cuts by 75% the time taken to identify patients carrying MRSA and could be used to help prevent transmission of the bacteria in hospitals.

7 Feb 2006